The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Longduoduo Co's quick ratio for the quarter that ended in Mar. 2026 was 1.54.
Longduoduo Co has a quick ratio of 1.54. It generally indicates good short-term financial strength.
The historical rank and industry rank for Longduoduo Co's Quick Ratio or its related term are showing as below:
LDDD'
s Quick Ratio Range Over the Past 10 Years
Min: 0.09 Med: 1.04 Max: 2.25
Current: 1.54
During the past 5 years, Longduoduo Co's highest Quick Ratio was 2.25. The lowest was 0.09. And the median was 1.04.
Longduoduo Co (OTCPK:LDDD) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Longduoduo Co Quick Ratio Related Terms
Longduoduo Co Quick Ratio Historical Data
* Premium members only.
The historical data trend for Longduoduo Co's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Longduoduo Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Longduoduo Co Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Longduoduo Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Longduoduo Co's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Longduoduo Co (LDDD) has a Quick Ratio of 1.54 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Longduoduo Co and its competitors. This is 48% above median its historical median of 1.04. Over the past decade, Longduoduo Co's Quick Ratio has ranged from 0.09 to 2.25.
Is Longduoduo Co's Quick Ratio too high?
Longduoduo Co's current Quick Ratio of 1.54 is 48% above median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 2.25. The Medical Diagnostics & Research industry median Quick Ratio is 1.67. Longduoduo Co's value of 1.54 is 7.8% below this industry median. Overall, Longduoduo Co has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Longduoduo Co's Quick Ratio compare to AWHL and BIAF?
Longduoduo Co's Quick Ratio of 1.54 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Quick Ratio is 1.67. Longduoduo Co's value of 1.54 is 7.8% below this benchmark. Historically, Longduoduo Co's own Quick Ratio has ranged from 0.09 to 2.25 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 1.67, Longduoduo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.67, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Longduoduo Co's current Quick Ratio of 1.54 is 7.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Longduoduo Co and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longduoduo Co's current Quick Ratio is 1.54, which is 48% above median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longduoduo Co stock overvalued right now?
Longduoduo Co (LDDD) has a current Quick Ratio of 1.54. The stock's GF Value™ is $2.30, compared to a current price of $0.51 — trading 77.8% below its estimated fair value. The current Quick Ratio is 1.54, which is 48% above median its 10-year median of 1.04 and 7.8% below the Medical Diagnostics & Research industry median of 1.67. Longduoduo Co's overall GF Score™ is 47/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Longduoduo Co (LDDD), the current Quick Ratio is 1.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Longduoduo Co (LDDD) Overvalued in 2026?
Based on GuruFocus' analysis, Longduoduo Co stock appears to be undervalued.
The current stock price of $0.51 is trading 77.8% below its estimated GF Value™ of $2.30.
Key valuation signals for LDDD:
Quick Ratio: 1.54 (48% above median its 10-year median of 1.04)
GF Value™: $2.30 vs. price of $0.51 (77.8% below fair value)
Industry Position: 7.8% below the Medical Diagnostics & Research median
No single metric tells the full story. See the LDDD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Longduoduo Co Ltd through its operating subsidiaries, is engaged in providing preventive healthcare solutions. It offers a wide range of comprehensive preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other related services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. Its revenues are mainly generated from customers in the People's Republic of China.
47GF Score
Get the complete analysis for LDDD
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LDDD has been successfully added to your 
